METHOD FOR RADIONUCLIDE DIAGNOSTICS OF LUNG CANCER Russian patent published in 2021 - IPC A61B6/03 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to radionuclide diagnostics, and can be used for radionuclide diagnostics of lung cancer. To implement the method, a radiopharmaceutical (RP) is administered and scintigraphic examination is performed. A radiopharmaceutical based on a technetium-99m-labeled glucose derivative in form of a solution for intravenous injection containing: 1-ito-D-glucose sodium salt hydrate 0.625 mg, tin 2-aqueous dichloride 0.044 to 0.052 mg, ascorbic acid 0.125 mg, sodium chloride 8.0 to 10.0 mg, water for injection up to 1 ml, is administered as an RP at a dose of 500 MBq. Single-photon emission computer tomography is performed 40 to 120 minutes after the intravenous administration of the pharmaceutical on a two-detector gamma camera, the patient is placed on the table of the gamma camera in the "supine" position during the procedure, wherein the ribcage from the upper aperture to the diaphragm level must be in view of the gamma camera detectors. The resulting images are postprocessed, and a malignant neoplasm is diagnosed in visualisation of asymmetric areas of the RP hyperfixation in a projection of the lungs.

EFFECT: method allows improving efficiency, accuracy and informational value of lung cancer diagnostics.

1 cl, 1 dwg, 1 ex